Bioemulous
Founded 2014
About Bioemulous
Leucillin is an FDA approved topical log 7 sanitiser used against bacterial, viral and fungal pathogens. It is a stable, Ph neutral, long shelf life hypochlorous acid solution witch is the same chemical as all mammals and humans produce at a cellular level to fight infection. The method by which Bioemulous Limited produces Leucillin is a unique innovation and due to its stability, efficacy, ability to scale into volume production and long shelf life it is being considered as a candidate for being declared an 'essential medicine' for all global health care systems and treatment centres by the World Health Organisation. As at March 2025 Leucillin has been approved in, and is being exported to, 56 countries from the United Kingdom.
Company Facts
- Founded: 2014
- Legal name: Bioemulous Limited
- Operating status: Operating
- IPO status: Private
- Employees: 11 – 50
- Website: leucillin.co.uk
- Phone: +44 (0)345 548 9800
Social Profiles
Canonical: https://fsome.com/organization/bioemulous-8371117 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.